Announcement on Branch Receiving Drug Registration Certificate
Filed with SSE · · 3 pages · Chinese
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Completing Term Change of the Board of Directors and Appointing Senior Management Members
- Announcement on Election of Employee Representative Director
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subsidiary
Later from Guangzhou Baiyunshan Pharmaceutical
- "Corporate Value and Return Enhancement" Action Plan 2026
- Announcement on Completion of Legal Representative Change Registration and Renewal of Business License
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Indicative Announcement on the Pre-Listing of the Capital Increase and Share Expansion of a Subsidiary
- Announcement on the Receipt of a Macao Drug Registration Certificate by a Branch
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical